- Home
- TWIN vs RGC Comparison
TWIN vs RGC Comparison
Compare TWIN & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TWIN | RGC |
|---|---|---|
| Founded | 1918 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.7M | 11.5B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TWIN | RGC |
|---|---|---|
| Price | $16.65 | $24.01 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 66.8K | ★ 90.9K |
| Earning Date | 05-06-2026 | 10-31-2025 |
| Dividend Yield | ★ 0.98% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.76 | N/A |
| Revenue | ★ $340,738,000.00 | N/A |
| Revenue This Year | $10.79 | N/A |
| Revenue Next Year | $8.43 | N/A |
| P/E Ratio | $9.50 | ★ N/A |
| Revenue Growth | ★ 15.45 | N/A |
| 52 Week Low | $7.29 | $9.39 |
| 52 Week High | $19.67 | $828.00 |
Technical Indicators
Market Signals| Indicator | TWIN | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 46.39 | 39.91 |
| Support Level | $16.46 | $21.81 |
| Resistance Level | $18.95 | $26.42 |
| Average True Range (ATR) | 1.01 | 1.85 |
| MACD | -0.07 | -0.39 |
| Stochastic Oscillator | 39.09 | 16.64 |
Price Performance
Historical ComparisonAbout TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.